Strategic partnerships The center is already a partner site with QuintilesIMS and INC Research, indicating a strong track record with CRO networks and potential for expanded collaborations on new trials and multi-site studies.

Clinical trial capacity Maintains a robust pipeline with 80-100 active Phase II–IV trials across multiple neurological indications, suggesting ample opportunities for sponsorships, site expansion, and patient recruitment services.

Patient-centric sales Experienced nurse coordinators and a focus on patient comfort and information flow present a compelling value proposition for sponsors prioritizing streamlined retention, adherence support, and high-quality data collection.

Financial potential Reported revenue range of 1–10 million with a specialized neurology focus and access to pharmaceutical-funded trial treatments, highlighting opportunities for new sponsor deals and broader scope of services.

Clinical focus breadth Expertise across Alzheimer’s, MS, Parkinson’s, stroke, sleep disorders, migraines, pediatric neurology, and seizures positions the center to attract diverse therapeutic programs and cross-indication trials from sponsors seeking neurology-centric sites.